[go: up one dir, main page]

PE20030890A1 - Cumarinas utiles como biomarcadores - Google Patents

Cumarinas utiles como biomarcadores

Info

Publication number
PE20030890A1
PE20030890A1 PE2003000207A PE2003000207A PE20030890A1 PE 20030890 A1 PE20030890 A1 PE 20030890A1 PE 2003000207 A PE2003000207 A PE 2003000207A PE 2003000207 A PE2003000207 A PE 2003000207A PE 20030890 A1 PE20030890 A1 PE 20030890A1
Authority
PE
Peru
Prior art keywords
noh
cumarinas
biomarkers
useful
formula
Prior art date
Application number
PE2003000207A
Other languages
English (en)
Inventor
Yves Auberson
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9932424&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20030890(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20030890A1 publication Critical patent/PE20030890A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE REFIERE AL COMPUESTO DE FORMULA (I), DONDE R1 Y R2 SON H, R3 Y R4 SON H, CH3, 11CH3, (CH2)nI, (CH2)n123I, (CH2)nOH, (CH2)nF, o (CH2)n18F, SIENDO n 2, 3 o 4, o R3 Y R4, JUNTO CON EL ATOMO DE NITROGENO CON EL QUE ESTAN UNIDOS FORMAN UN GRUPO DE FORMULA (II), DONDE R5 ES H, (CH2)nI, (CH2)n123I, (CH2)nOH, CH3, 11CH3, (CH2)nF o(CH2)n18F, SIENDO n COMO YA SE DEFINIO, O UNO DE R1 Y R2 ES H Y EL OTRO, JUNTO CON R3 FORMA UN PUENTE DE -(CH2)m-, DONDE m ES 2 o 3, Y R4 ES H, CH3, (CH2)nI, (CH2)n123I, (CH2)nOH, 11CH3, (CH2)nF o (CH2)n18F Y R ES UN GRUPO SELECCIONADO DE LAS FORMULAS (III), (IV) Y (V), DONDE X ES O, S o NR8, SIENDO R8 H, CH3, 11CH3, (CH2)nI, (CH2)n123I, (CH2)nOH, (CH2)nF o (CH2)n18F, Y ES CH o N, y R6 Y R7 SON INDEPENDIENTEMENTE H, NO2, F, 18F, O(CH2)nF, Cl, CN, 11CN, OCH3, O11CH3, I, 123I, O(CH2)nI o O(CH2)n123I, SIENDO n, EN AMBOS CASOS, COMO SE DEFINIO ANTERIORMENTE, EN FORMA DE BASE LIBRE O DE SAL DE ADICION DE ACIDO PARA UTILIZARSE COMO UN MARCADOR
PE2003000207A 2002-03-06 2003-03-04 Cumarinas utiles como biomarcadores PE20030890A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0205281.9A GB0205281D0 (en) 2002-03-06 2002-03-06 Organic compounds

Publications (1)

Publication Number Publication Date
PE20030890A1 true PE20030890A1 (es) 2003-12-05

Family

ID=9932424

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000207A PE20030890A1 (es) 2002-03-06 2003-03-04 Cumarinas utiles como biomarcadores

Country Status (24)

Country Link
US (1) US7569337B2 (es)
EP (1) EP1483262B1 (es)
JP (2) JP4247123B2 (es)
KR (1) KR20040095257A (es)
CN (1) CN1628114A (es)
AR (1) AR038723A1 (es)
AT (1) ATE378333T1 (es)
AU (1) AU2003210418A1 (es)
BR (1) BR0308211A (es)
CA (1) CA2472298A1 (es)
CO (1) CO5611123A2 (es)
DE (1) DE60317476T2 (es)
EC (1) ECSP045255A (es)
ES (1) ES2294304T3 (es)
GB (1) GB0205281D0 (es)
MX (1) MXPA04008570A (es)
NO (1) NO20044174L (es)
PE (1) PE20030890A1 (es)
PL (1) PL370916A1 (es)
PT (1) PT1483262E (es)
RU (1) RU2004129733A (es)
TW (1) TW200400049A (es)
WO (1) WO2003074519A1 (es)
ZA (1) ZA200405175B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205281D0 (en) * 2002-03-06 2002-04-17 Novartis Ag Organic compounds
WO2005040337A2 (en) * 2003-05-20 2005-05-06 The Regents Of The University Of California METHODS FOR BINDING AGENTS TO β-AMYLOID PLAQUES
JP2007084526A (ja) * 2004-11-26 2007-04-05 Nagasaki Univ アミロイド関連疾患診断用組成物
JP4000353B2 (ja) 2004-11-26 2007-10-31 国立大学法人 長崎大学 アミロイド関連疾患診断用組成物
TW200803903A (en) * 2006-04-28 2008-01-16 Nihon Mediphysics Co Ltd Novel compound having affinity to amyloid
US8303935B2 (en) * 2006-05-19 2012-11-06 Nihon Medi-Physics Co., Ltd. Alkoxy substituted imidazo[1,2-a]pyridines having affinity for amyloid
TW200811175A (en) * 2006-06-21 2008-03-01 Nihon Mediphysics Co Ltd Novel compound with affinity with amyloid
KR20090025282A (ko) 2006-06-21 2009-03-10 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물
ES2421886T3 (es) 2007-02-13 2013-09-06 Nihon Mediphysics Co Ltd Método para producción de un agente de representación de imágenes de diagnóstico por radiación
CN101903381A (zh) * 2007-10-24 2010-12-01 日本医事物理股份有限公司 对淀粉样蛋白具有亲和性的新化合物
AU2008319985A1 (en) * 2007-10-30 2009-05-07 Nihon Medi-Physics Co., Ltd. Use of novel compound having affinity for amyloid, and process for production of the same
CN101909659A (zh) * 2007-10-30 2010-12-08 日本医事物理股份有限公司 对淀粉样蛋白具有亲和性的新化合物的应用及制备方法
WO2013101974A1 (en) 2011-12-30 2013-07-04 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
WO2013109972A2 (en) 2012-01-20 2013-07-25 Regents Of The University Of Minnesota Therapeutic compounds
CA2862084C (en) 2012-01-26 2021-05-11 Ptc Therapeutics, Inc. 1h-isochromen-1-one derivatives and compositions thereof for treating spinal muscular atrophy
EP3406252B1 (en) 2012-02-10 2020-05-13 PTC Therapeutics, Inc. Compounds for treating spinal muscular atrophy
CN104302181B (zh) * 2012-03-01 2017-09-15 Ptc医疗公司 用于治疗脊髓性肌萎缩的化合物
KR102109992B1 (ko) 2012-03-23 2020-05-13 피티씨 테라퓨틱스, 인크. 척수성 근위축증을 치료하기 위한 화합물
CN103420990B (zh) * 2012-05-23 2016-04-20 复旦大学 7-氧、硫或氮杂取代香豆素及其衍生物和用途
EP3082820B1 (en) 2013-12-19 2022-07-20 PTC Therapeutics, Inc. Methods for modulating the amount of rna transcripts
EP4249472A3 (en) 2015-05-30 2023-12-13 PTC Therapeutics, Inc. Methods for modulating rna splicing
EA201800367A1 (ru) 2015-12-10 2019-02-28 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способы лечения болезни хантингтона
EP3544435A4 (en) 2016-11-28 2020-11-04 PTC Therapeutics, Inc. RNA SPLICE MODULATION PROCESSES
EP4257596A3 (en) 2016-12-22 2023-12-06 Illumina Cambridge Limited Coumarin compounds and their uses as fluorescent labels
CN108061725B (zh) * 2017-02-16 2020-04-21 昆明医科大学 1,8-萘啶基荧光分子探针在氯胺酮娱乐性滥用神经机制研究及成瘾程度诊断中的应用
JP7376471B2 (ja) 2017-06-05 2023-11-08 ピーティーシー セラピューティクス, インコーポレイテッド ハンチントン病を処置するための化合物
WO2018232039A1 (en) 2017-06-14 2018-12-20 Ptc Therapeutics, Inc. Methods for modifying rna splicing
BR112019027717A2 (pt) 2017-06-28 2020-07-28 Ptc Therapeutics, Inc. métodos para tratar a doença de huntington
US11395822B2 (en) 2017-06-28 2022-07-26 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
AU2019243048A1 (en) 2018-03-27 2020-10-15 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
BR112020026534A2 (pt) 2018-06-27 2021-03-23 Ptc Therapeutics, Inc. Compostos de heteroarila para o tratamento da doença de huntington
SI3814357T1 (sl) 2018-06-27 2024-09-30 Ptc Therapeutics, Inc. Heterociklične in heteroarilne spojine za zdravljenje Huntingtonove bolezni
WO2020005882A1 (en) 2018-06-27 2020-01-02 Ptc Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
MX2020013384A (es) * 2019-03-01 2021-04-28 Illumina Cambridge Ltd Compuestos de comarina sustituidos con amina exocíclica y sus usos como etiquetas fluorescentes.
CN112300201B (zh) * 2020-12-07 2021-11-23 南京林业大学 一种三聚茚基香豆素-咔咯-卟啉四元体系星型化合物的合成及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH390250A (de) * 1958-06-19 1965-07-30 Geigy Ag J R Verfahren zur Herstellung von fluoreszierenden Farbstoffen
DE2030507C3 (de) * 1970-06-20 1975-05-22 Bayer Ag, 5090 Leverkusen Oxazolyl-cumarine, deren Herstellung und Verwendung
JPS5529110B2 (es) * 1972-12-25 1980-08-01
DE2410634A1 (de) * 1974-03-06 1975-09-18 Basf Ag 3-benzofurylcumarine
DE2411969A1 (de) * 1974-03-13 1975-09-25 Bayer Ag Farbstofflaser
DE2525986A1 (de) * 1975-06-11 1977-05-05 Bayer Ag Cumarinverbindungen
LU78311A1 (de) * 1977-10-13 1979-06-01 Ciba Geigy Ag Neue cumarinfarbstoffe,deren herstellung und verwendung
US4892922A (en) * 1987-11-30 1990-01-09 Eastman Kodak Company Polyester polymer containing the residue of a benzopyran colorant compound and shaped articles produced therefrom
JPH01169327A (ja) * 1987-12-25 1989-07-04 Mitsui Toatsu Chem Inc 紫外線検知用樹脂組成物
JP2999841B2 (ja) * 1991-04-03 2000-01-17 三井化学株式会社 発光スクリーン用樹脂組成物
DE69216498T2 (de) 1991-08-13 1997-04-30 Bayer Ag Fluoreszierendes Etikett
JPH073179A (ja) * 1993-06-15 1995-01-06 Nippon Kayaku Co Ltd インクジェットプリント用インク組成物及びこれを用いる染色法
JP4028155B2 (ja) * 2000-04-11 2007-12-26 日本カーバイド工業株式会社 蛍光性再帰反射シート
GB0205281D0 (en) * 2002-03-06 2002-04-17 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
CO5611123A2 (es) 2006-02-28
CN1628114A (zh) 2005-06-15
GB0205281D0 (en) 2002-04-17
KR20040095257A (ko) 2004-11-12
NO20044174L (no) 2004-09-30
JP4247123B2 (ja) 2009-04-02
DE60317476D1 (de) 2007-12-27
US7569337B2 (en) 2009-08-04
PL370916A1 (en) 2005-06-13
JP2005526749A (ja) 2005-09-08
AU2003210418A1 (en) 2003-09-16
RU2004129733A (ru) 2005-06-27
EP1483262A1 (en) 2004-12-08
DE60317476T2 (de) 2008-05-21
CA2472298A1 (en) 2003-09-12
ECSP045255A (es) 2004-09-28
BR0308211A (pt) 2004-12-21
JP2009102322A (ja) 2009-05-14
PT1483262E (pt) 2008-02-11
AR038723A1 (es) 2005-01-26
MXPA04008570A (es) 2004-12-06
EP1483262B1 (en) 2007-11-14
US20050169837A1 (en) 2005-08-04
ZA200405175B (en) 2005-06-21
WO2003074519A1 (en) 2003-09-12
ES2294304T3 (es) 2008-04-01
TW200400049A (en) 2004-01-01
ATE378333T1 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
PE20030890A1 (es) Cumarinas utiles como biomarcadores
ECSP045369A (es) Derivados de n-[fenil(piperidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica
AR036093A1 (es) Compuestos derivados de tiazolidinilo, pirrolidinilo, oxazolidinilo, piperidilo, morfolinilo y tiomorfolinilo, su uso, composiciones farmaceuticas que los comprenden, y compuestos intermediarios
CO5640132A2 (es) Piridinonas sustituidas
EA200201056A1 (ru) Новые, обладающие продолжительным действием бетамиметики, способ их получения и их применение в качестве лекарственных средств
HRP20020539B1 (hr) Novi modulatori transmisije dopamina
HRP20110425T1 (en) Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
CO5690596A2 (es) Derivados de hexahidropirazino [1,2-a]pirimidin-4,7-diona sustituidos, en el nitrogeno, metodo para su produccion y su uso como medicamentos
PE20021091A1 (es) Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion
AR042149A1 (es) Uso de aminas y/o aductos de mannich en composiciones de combustibles y lubricantes para motores otto de inyeccion directa
ECSP034475A (es) Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1
EA200300763A1 (ru) Пиридиновые ингибиторы матриксных металлопротеиназ
ATE282614T1 (de) Phenylharnstoff und phenylthioharnstoffderivate
AR049291A1 (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
AR021533A1 (es) Derivados de 2,5-diazabiciclo[2.2.1]heptano, su preparacion y su aplicacion en terapeutica
CO5031250A1 (es) Compuesto farmaceutico
MEP24208A (en) Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
AR061835A1 (es) Derivados tetraciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR028647A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonano benzoxazol, benzotiazol y bencimidazol, su preparacion y su aplicacion en terapéutica
BRPI0508072A (pt) derivados de piperidinilalquicarbamatos, o respectivo preparo e a respectiva aplicação como inibidores da enzima faah
CO5690582A2 (es) Derivados de n-tiazol-2-il-benzamida
ATE433440T1 (de) Harnstoff-linker verbindungen und ihre verwendung als ppar regulatoren
CO5601030A2 (es) Derivados de quinolinona/benzoxazinona y usos de los mismos
CO5690598A2 (es) 6-[(sustituido)fenil]triazolopirimidinas como agentes anticancer
PE20011137A1 (es) Inhibidores de las metaloproteasas que contienen cadenas laterales heterociclicas n-sustituidas

Legal Events

Date Code Title Description
FA Abandonment or withdrawal